Company
A new era for human health
Welcome to our Canadian website. GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.
A signal for change
1:48
Our strategy
We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.
$3 mil +
contributed over the last 20 years to support the hospice palliative care movement in Canada
GSK Global links
Visit our Global site for additional features
Press releases
- Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk
- GSK and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for JEMPERLI for the treatment of patients with recurrent or advanced dMMR/MSI-H endometrial cancer
- Data from new national study exposes oral corticosteroids overuse in Canadian patients with severe asthma
Choose your path
By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the world’s health.
